By Maggie Fick and Jennifer Rigby LONDON (Reuters) -Drugmakers Bharat Biotech and GSK will cut the price of their malaria ...

Oxford researchers have developed a single-shot malaria vaccine using programmable microcapsules that release booster doses ...

The innovative vaccine delivery system can provide full course of immunisation - both initial and booster doses.

As part of a multi-year collaboration, GSK and India’s Bharat Biotech are redoubling their efforts to bring the world’s first malaria vaccine to more countries in need at affordable prices. | The ...

FRIDAY, June 27, 2025 (HealthDay News) — The United States will stop sending money to Gavi, a global group that helps ...

Bharat Biotech International Ltd and GSK plc on Wednesday said they will reduce the price of the world's first malaria ...

Bharat Biotech and GSK have announced plans to reduce the price of their malaria vaccine, Mosquirix, to $5 per dose by 2028.

Bharat Biotech and GSK plc will significantly reduce the price of their malaria vaccine, Mosquirix, to under $5 per dose by ...

As the deadly grip of malaria continues to claim thousands of lives each year, a powerful shift is underway in Uganda—one ...

Kennedy called on Gavi “to re-earn the public trust and to justify the $8 billion America has provided in funding since 2001, ...

Bharat Biotech has entered into partnership in 2021 to produce part of the malaria vaccine that has been developed by British ...

Bharat Biotech and GSK to reduce RTS,S malaria vaccine price to under $5 per dose by 2028, enhancing access for children in ...